Novel Cross-Correction-Enabled Gene Therapy for CDKL5-Deficiency Disorder.
Nitschke F, Montalbano AP, 2022 Oct NeurotherapeuticsGlycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
Nitschke S, Sullivan MA, Mitra S, Marchioni CR, Lee JPY, Smith BH, Ahonen S, Wu J, Chown EE, Wang P, Petkovic S, Zhao X, DiGiovanni LF, Perri AM, Israelian L, Grossman TR, Kordasiewicz H, Vilaplana F, Iwai K, Nitschke F, Minassian BA, 2022 Jan BrainAbnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
Nitschke F, Sullivan MA, Wang P, Zhao X, Chown EE, Perri AM, Israelian L, Juana-López L, Bovolenta P, Rodríguez de Córdoba S, Steup M, Minassian BA, 2017 07 EMBO Mol Med 7 9 906-917Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
Sullivan MA, Nitschke S, Steup M, Minassian BA, Nitschke F, 2017 Aug Int J Mol Sci 8 18Update on pharmacological treatment of Progressive Myoclonus Epilepsies.
Ferlazzo E, Trenite DK, de Haan GJ, Felix Nitschke F, Ahonen S, Gasparini S, Minassian BA 2017 Aug Curr. Pharm. Des.Efficient Delivery of Structurally Diverse Protein Cargo into Mammalian Cells by a Bacterial Toxin.
Auger A, Park M, Nitschke F, Minassian LM, Beilhartz GL, Minassian BA, Melnyk RA, 2015 Aug Mol. Pharm. 8 12 2962-71Transition from glycogen to starch metabolism in Archaeplastida.
Cenci U, Nitschke F, Steup M, Minassian BA, Colleoni C, Ball SG, 2014 Jan Trends Plant Sci. 1 19 18-28